{"text": "In this study, we demonstrated for the first time that co-targeting of N-Myc and Bcl-2 resulted in marked synergistic antitumor effects in MYCN-amplified SCLC. Our study demonstrates a new JQ-1/ABT-263 co-targeting strategy that can be employed for MYCN-amplified SCLC with high efficacy.", "denotations": [{"id": "T1", "obj": "gene", "span": {"begin": 81, "end": 86}}, {"id": "T2", "obj": "disease", "span": {"begin": 118, "end": 127}}, {"id": "T3", "obj": "disease", "span": {"begin": 139, "end": 158}}]}
